Back
Conditional Replication Adenovirus Sensitizes A549 Cancer Cell to Cisplatin
Yanan Liu, Yinghui Huang
Engineering Vol.4 No.10, October 21, 2013  DOI: 10.4236/eng.2012.410B043
       (PDF  109K)     HTML     
Antitumor Effects of Conditional Replication Adenovirus in Combination with Cisplatin on Lung Cancer
Yanan Liu, Yinghui Huang
Engineering Vol.4 No.10, October 21, 2013  DOI: 10.4236/eng.2012.410B042
       (PDF  116K)     HTML     
Outcomes of Quality of Life Regarding the Next-Generation Thoracoscopic Intrapleural Hyperthermic Chemotherapy of Non-Small Cell Lung Cancer with Dissemination
Takanori Ayabe, Masaki Tomita, Eiichi Chosa, Kosuke Mori, Kunihide Nakamura
J. Cancer Ther. Vol.7 No.1, January 28, 2016  DOI: 10.4236/jct.2016.71008
       (PDF  1833K)     HTML      XML
Combination Treatment with BEC and Cisplatin Synergistically Augments Anticancer Activity and Results in Increased Absolute Survival
B. E. Cham
J. Cancer Ther. Vol.11 No.8, August 18, 2020  DOI: 10.4236/jct.2020.118040
       (PDF  496K)     HTML      XML
Practical Use of Gemcitabine and Cisplatin Combination Therapy as First-Line Treatment for Japanese Patients with Advanced Biliary Tract Cancer
Hisato Kawakami, Isamu Okamoto, Wataru Okamoto, Masayuki Takeda, Shinya Ueda, Toshihiro Kudo, Shin-ichi Nishina, Yasuhito Fujisaka, Masaki Miyazaki, Junji Tsurutani, Takayasu Kurata, Kazuhiko Nakagawa
J. Cancer Ther. Vol.4 No.6, July 17, 2013  DOI: 10.4236/jct.2013.46121
       (PDF  186K)     HTML     
 
 
Top